About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
RYTM
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Rhythm Pharmaceuticals reports mixed Q4 results; initiates FY24 outlook
- Rhythm Pharmaceuticals Q4 2023 Earnings Preview
- J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up
- Rhythm completes screening for Phase 3 anti-obesity study
- Rhythm to acquire rights to Phase 2 anti-obesity drug from LG Chem
- Pfizer hits new 52-week low after weight loss setback
- Rhythm Pharmaceuticals GAAP EPS of -$0.76 in-line, revenue of $22.5M beats by $0.32M
- Rhythm Pharmaceuticals Q3 2023 Earnings Preview
- Rhythm’s obesity therapy granted EU backing for orphan designation
- Nearly half of U.S. adults want weight-loss drugs – KFF poll
- Rhythm Pharma surges on strong Q2 sales; BofA upgrades
- Rhythm Pharmaceuticals GAAP EPS of -$0.82 misses by $0.04, revenue of $19.22M beats by $4.19M
- Rhythm Pharmaceuticals Q2 2023 Earnings Preview
- Morgan Stanley sees broader MedTech impact from weight loss drugs
- Rhythm Pharma wins Canadian nod for weight loss therapy
- Spending on weight loss drugs to rise 378% in 2023 – 2027: report
- Rhythm Pharmaceuticals reports misses Q1 top and bottom consensus; reaffirms FY23 outlook
- Lilly obesity therapy shows ~16% weight loss in Phase 3 trial
- Pfizer CEO Albert Bourla backs FDA after abortion pill ruling
- WHO to weigh adding obesity therapies to 'essential' medicines list – Reuters
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4 | 9.27 | 8.64 |
9.35
|
8.64
|
421.57K | 4.27% | ||||
| Mar 3 | 8.89 | 9.25 |
9.30
|
8.67
|
468.00K | -3.79% | ||||
| Mar 2 | 9.24 | 8.68 |
9.26
|
8.59
|
597.84K | 8.83% | ||||
| Mar 1 | 8.49 | 7.87 |
8.63
|
7.78
|
600.82K | 11.42% | ||||
| Feb 28 | 7.62 | 7.26 |
7.71
|
7.07
|
639.34K | 2.56% | ||||
| Feb 25 | 7.43 | 7.31 |
7.47
|
7.00
|
481.45K | 2.34% | ||||
| Feb 24 | 7.26 | 7.52 |
7.61
|
6.22
|
1.87M | -13.26% | ||||
| Feb 23 | 8.37 | 8.39 |
8.71
|
8.27
|
799.77K | 0% | ||||
| Feb 22 | 8.37 | 7.97 |
8.80
|
7.86
|
697.25K | 3.98% | ||||
| Feb 18 | 8.05 | 7.52 |
8.42
|
7.52
|
1.29M | 4.55% | ||||
| Feb 17 | 7.70 | 7.23 |
7.92
|
7.02
|
1.63M | 16.14% | ||||
| Feb 16 | 6.63 | 6.70 |
6.79
|
6.49
|
404.13K | -2.36% | ||||
| Feb 15 | 6.79 | 6.35 |
6.86
|
6.32
|
791.74K | 10.77% | ||||
| Feb 14 | 6.13 | 6.19 |
6.28
|
6.01
|
588.56K | 0% | ||||
| Feb 11 | 6.13 | 6.29 |
6.52
|
6.12
|
691.57K | -3.46% | ||||
| Feb 10 | 6.35 | 6.55 |
6.80
|
6.25
|
922.87K | -6.62% | ||||
| Feb 9 | 6.80 | 6.62 |
6.89
|
6.52
|
672.96K | 5.59% | ||||
| Feb 8 | 6.44 | 6.91 |
6.94
|
6.37
|
352.66K | -5.71% | ||||
| Feb 7 | 6.83 | 6.61 |
6.92
|
6.55
|
459.18K | 3.64% | ||||